-
Whereas its potential benefits remain uncertain, prostate-specific antigen (PSA) screening may be associated with psychological harms. There has been a recent update to the screening guidelines by the U.S. Preventive Services Task Force (USPSTF).
-
The vaccines available today afford benefit to a wide range of ages: infants, adolescents, adults, and the elderly. Many of the vaccines provide a proactive response to the conditions that were treated only retrospectively just a few years ago.1
-
The Tennessee Pharmacists Association (TPA) report that the Tennessee Pharmacists Research and Education Foundation has received a total research grant of $425,040 from Roche Diagnostics.
-
Hospital-acquired infections with methicillin-resistant S. aureus (MRSA) have increased tremendously in recent years, with one study finding that MRSA-related hospitalizations in the United States more than doubled between 1999 and 2005.
-
If your practice includes care of those ages 45 and older, be prepared to discuss risk of sexually transmitted disease (STD) infection.
-
The woman in your next examination room tells you she has a long-term partner who has multiple sexual contacts. While she says she is concerned about protection against HIV, she admits she cannot convince her partner to use a male condom. What is your next move?
-
-
Add a new resource on menopause management to your clinical practice. The North American Menopause Society (NAMS) has just updated its guidelines on postmenopausal hormone therapy.
-
Regulatory review of a second human papillomavirus (HPV) vaccine has been delayed. GlaxoSmithKline has announced plans to submit additional data from its large-scale clinical trial for its vaccine candidate, Cervarix.
-
If your clinic is using oral fluid samples for rapid HIV testing, be sure to monitor for false-positive results.